ResMed Inc.
General ticker "RSMDF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $39.0B (TTM average)
ResMed Inc. does not follow the US Stock Market performance with the rate: -5.6%.
Estimated limits based on current volatility of 0.2%: low 16.68$, high 16.75$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-05-14, amount 0.06$ (Y1.44%)
- Total employees count: 10600 (+6.2%) as of 2025
- US accounted for 63.6% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Inability to compete, Healthcare consolidation and payment reform, Geopolitical risks, Public health crises, Clinical trial success
Short-term RSMDF quotes
Long-term RSMDF plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $4,222.99MM | $4,685.30MM | $5,146.33MM |
| Operating Expenses | $3,091.12MM | $3,365.40MM | $3,460.96MM |
| Operating Income | $1,131.87MM | $1,319.89MM | $1,685.36MM |
| Non-Operating Income | $-30.21MM | $-55.09MM | $-7.80MM |
| R&D Expense | $287.64MM | $307.52MM | $331.28MM |
| Income(Loss) | $1,101.66MM | $1,264.80MM | $1,677.57MM |
| Taxes | $204.11MM | $243.85MM | $276.84MM |
| Net Income(Loss)* | $897.56MM | $1,020.95MM | $1,400.72MM |
| Stockholders Equity | $4,129.90MM | $4,864.04MM | $5,967.86MM |
| Inventory | $998.01MM | $822.25MM | $927.71MM |
| Assets | $6,751.71MM | $6,872.39MM | $8,174.39MM |
| Operating Cash Flow | $693.30MM | $1,401.26MM | $1,751.59MM |
| Capital expenditure | $134.00MM | $114.86MM | $89.86MM |
| Investing Cash Flow | $-1,159.85MM | $-269.78MM | $-200.04MM |
| Financing Cash Flow | $422.87MM | $-1,119.29MM | $-606.25MM |
| Earnings Per Share** | $6.12 | $6.94 | $9.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.